Cancer diagnostics News and Research

RSS

Population-based mammography programmes still save significant number of lives

A Dutch study of the effectiveness of breast cancer screening shows that, even with improved treatments for the disease, population-based mammography programmes still save a significant number of lives.

22 Mar 2012

Low bone density drugs may protect women from endometrial cancer

Low bone density medications, such as Fosamax, Boniva and Actonel, may have a protective effect for endometrial cancer, according to a study at Henry Ford Hospital.

22 Mar 2012

Fox Chase to present best practices in cancer survivorship at 17th NCCN conference

People are living longer with and after a cancer diagnosis, making survivorship clinics and programs-as well as official guidelines and practices governing the care of survivors-an important emerging component of modern cancer care. Many institutions are looking to gather these resources into an easily understandable plan for their survivors.

20 Mar 2012

Lilly Oncology, NCCS to launch 2012 art competition and exhibition

Get your canvases, paintbrushes and cameras ready -- the subject is cancer and you are the storyteller. Lilly Oncology and the National Coalition for Cancer Survivorship (NCCS) today announced the launch of the 2012 Lilly Oncology On Canvas: Expressions of a Cancer Journey Art Competition and Exhibition.

17 Mar 2012

Solos to introduce new endoscopic instrument line, SteriTAP

Solos Endoscopy, Inc. is pleased to announce that the Company will be launching a new endoscopic instrument line, SteriTAP.

17 Mar 2012

Panel of 10 serum protein biomarkers could help in lung cancer diagnosis

A panel of serum biomarkers could help predict the level of lung cancer risk in high-risk patients, offering doctors an option before proceeding with a biopsy. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that a panel of 10 serum protein biomarkers could help in the lung cancer diagnosis.

16 Mar 2012

NCCN issues new guidelines for AYA oncology patients

The National Comprehensive Cancer Network announces that it has issued new NCCN Clinical Practice Guidelines in Oncology for Adolescent and Young Adult (AYA) Oncology. AYA patients are defined in the guidelines as individuals 15 to 39 years of age at initial cancer diagnosis.

9 Mar 2012

Butler Hospital expands Outpatient Psychiatric Consultation Program

In a move that highlights collaboration across a health care system, three Care New England hospitals recently came together to pilot a service that is now being expanded to fill a need for mental health services in the entire region. After successfully piloting the concept at Women & Infants and Kent hospitals, Butler Hospital is expanding its Outpatient Psychiatric Consultation Program to all referring physicians in the area who may have a patient needing a consult.

6 Mar 2012

Novel partnership could transform breast cancer diagnosis

An innovative University of Sydney research partnership with private enterprise could see a radical change in how breast cancer is diagnosed, with the possibility to improve detection rates.

4 Mar 2012

Promising results from initial trial of new ultrasonic breast cancer screening

Scientists have successfully completed an initial trial of a new, potentially more reliable, technique for screening breast cancer using ultrasound. The team at the National Physical Laboratory (NPL), the UK's National Measurement Institute, working with the University Hospitals Bristol NHS Foundation Trust, are now looking to develop the technique into a clinical device.

3 Mar 2012

Older women face increased risk of late stage breast cancer diagnosis

Older women with breast cancer face a higher risk of being diagnosed with the disease at a late stage, while the risk of an advanced stage diagnosis of lung cancer decreases with age, a new study shows today.

3 Mar 2012

Asuragen introduces miRInform test for diagnosis of pancreatic ductal adenocarcinoma

Asuragen, Inc. announced today the immediate availability of the miRInform® Pancreas Test in its CAP-accredited CLIA Laboratory. miRInform® Pancreas was developed to aid physicians in the diagnosis and management of pancreatic ductal adenocarcinoma (PDAC) when cytology is inconclusive. The test evaluates expression levels of seven miRNAs in Fine Needle Aspirate (FNA) specimens of pancreatic masses.

17 Feb 2012

Abcodia, Volition announce collaboration agreement

VolitionRX Limited, a life sciences company focused on developing blood-based diagnostic tests, announces a collaboration agreement with Abcodia, a specialist company spun out from University College London (UCL), under which Volition will gain access to Abcodia's biobank of over 5,000,000 human serum samples to validate its suite of NuQ tests.

17 Feb 2012

Women with cancer have worse health behaviors after mammography

A recent study conducted by researchers at Moffitt Cancer Center in Tampa, Fla., and the Mayo Clinic in Rochester, Minn., has found that female cancer survivors receiving screening mammography have "worse health behaviors" than women receiving mammography screening and who had never had cancer.

16 Feb 2012

Gen-Probe receives FDA approval for PROGENSA PCA3 assay

DiagnoCure, Inc., a Quebec life sciences company that develops and commercializes high‐value cancer diagnostic tests, announced today that the US Food and Drug Administration (FDA) has approved Gen-Probe's PROGENSA PCA3 (Prostate Cancer Antigen 3) assay, the first molecular test to help determine the need for repeat prostate biopsies in men who have had a previous negative biopsy.

15 Feb 2012

Boston Scientific launches Expect 19 Flex Endoscopic Ultrasound Aspiration Needle

Boston Scientific Corporation announces the global launch of the Expect 19 Flex Endoscopic Ultrasound Aspiration Needle, used for acquiring tissue samples under Endoscopic Ultrasound (EUS) guidance for cancer diagnosis in organs adjacent to the gastrointestinal tract.

6 Feb 2012

Cancer Genomics now available online

Genome Research publishes online and in print today a special issue entitled, "Cancer Genomics," highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer.

2 Feb 2012

Capital Health installs GE Discovery NM 750b scanner at N.J. Hopewell medical center

Capital Health and GE Healthcare announced today the first Discovery NM 750b was installed at Capital Health's New Jersey Hopewell medical center. Capital Health is a central New Jersey region leader in advanced medicine, with significant investments in advanced technologies and its medical staff.

31 Jan 2012

Non-smoking, non-drinking transplant patients more likely to develop head and neck cancer

Transplant patients who develop head and neck cancer are more likely to be non-smokers and non-drinkers, and less likely than their non-transplant counterparts to survive past one year of diagnosis, according to a new study from Henry Ford Hospital in Detroit.

30 Jan 2012

GenPath, BioReference Labs to introduce OnkoMatch solid tumor genotype test

BioReference Laboratories, Inc. and its GenPath Oncology business unit and through its exclusive commercialization agreement with the Massachusetts General Hospital (MGH) is introducing its groundbreaking solid tumor genotype test.

27 Jan 2012